Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.880
+0.250 (15.34%)
At close: May 15, 2026, 4:00 PM EDT
1.825
-0.055 (-2.93%)
Pre-market: May 18, 2026, 6:07 AM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $28.48 million as of May 18, 2026. Its market cap has increased by 298.14% in one year.
Market Cap
28.48M
Enterprise Value
25.35M
1-Year Change
298.14%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $28.48M, a decrease of -93.04%. That is a compound annual growth rate of -18.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 28.48M | 215.44% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 19.23M |
| Lipocine | 18.70M |
| NewcelX | 18.47M |
| Cocrystal Pharma | 17.37M |
| Passage Bio | 17.19M |
| SeaStar Medical Holding | 16.79M |
| Cadrenal Therapeutics | 16.22M |
| IN8bio | 15.66M |